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Macroautophagy is a fundamental and evolutionarily conserved catabolic process that eradicates damaged and aging
macromolecules and organelles in eukaryotic cells. Decorin, an
archetypical small leucine-rich proteoglycan, initiates a protracted autophagic program downstream of VEGF receptor 2
(VEGFR2) signaling that requires paternally expressed gene 3
(PEG3). We have discovered that PEG3 is an upstream transcriptional regulator of transcription factor EB (TFEB), a master
transcription factor of lysosomal biogenesis, for decorin-evoked
endothelial cell autophagy. We found a functional requirement
of PEG3 for TFEB transcriptional induction and nuclear translocation in human umbilical vein endothelial and PAER2 cells.
Mechanistically, inhibiting VEGFR2 or AMP-activated protein
kinase (AMPK), a major decorin-activated energy sensor kinase,
prevented decorin-evoked TFEB induction and nuclear localization. In conclusion, our findings indicate a non-canonical
(nutrient- and energy-independent) mechanism underlying the
pro-autophagic bioactivity of decorin via PEG3 and TFEB.

The extracellular matrix is becoming a prominent and
encompassing field of research; protein/protein interactions
and enzymatic processing often lead to profound effects on the
embedded cells and tissues (1– 6). An emerging paradigm for
extracellular matrix constituents, predominantly represented
by soluble proteoglycans (7, 8), is autophagic regulation (9).
Decorin, a prototypical member of the small leucine-rich proteoglycan gene family (10), directly interacts with a diverse set
of receptor tyrosine kinases as a partial agonist for various biological activities (11–13), culminating in anti-oncogenic and
angiostatic responses (14 –17), both in vitro (18, 19) and in vivo
(20 –22).
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High-resolution transcriptomics following systemic administration of decorin in triple-negative breast carcinoma orthotopic xenografts revealed differential gene expression exclusively within the tumor stroma (22). Among the subset of
decorin-inducible genes was a genomically imprinted transcription factor of the Krüppel zinc finger family known as
paternally expressed gene 3 (PEG3)3 (23, 24). PEG3 is a tumor
suppressor (25, 26) whose expression is commonly lost because
of promoter methylation (27, 28) or loss of heterozygosity (29).
We focused on PEG3 as both decorin and PEG3 disrupt Wnt
signaling in a non-canonical way, independent of GSK3␤ (18,
30). During the course of these studies, we discovered that
PEG3 was directly involved in regulating endothelial cell
autophagy following exposure to either soluble decorin proteoglycan or its protein core (31, 32). Silencing PEG3 prevented
induction of Beclin 1 and LC3 (31), two key components of the
autophagic machinery (33). Moreover, PEG3 was required for
maintaining basal levels of Beclin 1. Mechanistically, decorin
requires the tyrosine kinase activity of vascular endothelial
growth factor receptor 2 (VEGFR2), the dominant receptor
tyrosine kinase expressed by endothelial cells (31).
Decorin modulates the phosphorylation of critical rheostatic
kinases (AMPK and mammalian target of rapamycin (mTOR))
for maintaining the proper cellular balance of autophagy (34 –
37). Indeed, AMPK and mTOR (a primary component of
mTORC1) play opposing roles in autophagic regulation, as
AMPK is required for the initiation of autophagy via ULK1
phosphorylation (37– 40) and mTOR for autophagic inhibition
and termination (41, 42). We found sustained activation of the
AMPK␣ catalytic subunit with concurrent suppression of
mTOR signaling in endothelial cells (34). Notably, decorinevoked autophagy occurs under nutrient-rich conditions, designating decorin as a non-canonical stimulus for autophagic
induction.
The biosynthesis of new lysosomes is critical for achieving
the objective of cargo degradation and nutrient recycling via the
formation of terminal autophagolysosomes (43). Further, pro3

The abbreviations used are: PEG, paternally expressed gene; VEGFR, VEGF
receptor; AMPK, AMP-activated protein kinase; mTOR, mammalian target
of rapamycin; TFEB, transcription factor EB; HUVEC, human umbilical vein
endothelial cell; qPCR, quantitative real-time PCR; ZF, zinc finger; DIC, differential interference contrast; ANOVA, analysis of variance; siScr, scramble
siRNA.
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longed (or, in the case of decorin, excessive) autophagy depends
on stable transcriptional programs capable of supporting longterm autophagic processes (44 – 46). Therefore, we focused on
transcription factor EB (TFEB), a master regulator of lysosomal
biogenesis with direct links to autophagic progression (47–51).
Under anabolic conditions, activated mTORC1 directly phosphorylates TFEB, tethering it (in an inactive configuration) at
the lysosomal surface via interactions with 14-3-3 proteins (52).
This posits mTOR as a central regulator of TFEB function (43,
53, 54). Following autophagic stimulation or stress responses,
TFEB is dephosphorylated by calcineurin and translocates to
the nucleus for lysosomal gene expression by targeting a subset
of genes collectively known as the Coordinated Lysosomal
Expression and Regulation (CLEAR) network (47, 48).
As decorin suppresses mTOR activity and initiates prolonged autophagic responses, we evaluated the existence of a
mechanistic link between PEG3 and TFEB for endothelial cell
autophagy. We found that PEG3 is required for TFEB induction
and nuclear translocation in a VEGFR2- and AMPK-dependent
manner for decorin-evoked autophagy.

Results
Decorin-evoked PEG3 is required for TFEB induction
To evaluate a potential mechanistic link between PEG3 and
TFEB, we conducted time course experiments in both human
umbilical vein endothelial cells (HUVECs) and porcine aortic
endothelial cells overexpressing VEGFR2 (PAER2). We found
that PEG3 levels increased earlier and at a faster rate than TFEB
induction at the same time points (Fig. 1, A and C). In HUVECs,
following 9 h of decorin treatment, both PEG3 and TFEB levels
were maximal and began to decline but remained high even at
24 h (Fig. 1, A and B). Further, the relative kinetics of Peg3 and
Tfeb in PAER2 displayed a similar profile (Fig. 1C) insofar as
Peg3 increased first, followed by a more gradual induction of
Tfeb over time. However, unlike in HUVECs, Tfeb levels
declined to baseline after reaching peak levels (at 9 h) whereas
Peg3 remained elevated (Fig. 1D). We note that no differences
in bioactivity were found between decorin and decorin core in
this study (data not shown).
As the kinetics showed that PEG3 levels preceded those of
TFEB, we evaluated the functional requirement of PEG3 for
TFEB induction. After verification of PEG3 depletion (Fig. 1E),
we found that TFEB was no longer induced following decorin
treatment at either the mRNA (Fig. 1F) or protein (Fig. 1G)
levels. Intriguingly, we found that loss of PEG3 alone was sufficient for decreasing basal TFEB protein (Fig. 1G) but not
mRNA. These results are similar to the effect of PEG3 loss on
Beclin 1 (31). In reciprocal experiments where TFEB was
silenced (Fig. 1H), we found no significant change in PEG3
mRNA (Fig. 1I). These data suggest that TFEB is downstream of
PEG3. In accordance with our previous studies (31), we found
that decorin does not evoke PEG3 expression in endothelial
cells (Fig. 1, E and I). In contrast, endorepellin, a matrix-derived
molecule capable of inducing endothelial cell autophagy via
VEGFR2, evokes PEG3 mRNA levels (55–57). Finally, loss of
TFEB did not abrogate decorin-evoked PEG3 protein levels
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(Fig. 1J) and had no appreciable effect on basal levels of PEG3
mRNA or protein (Fig. 1, I and J).
De novo expression of Peg3 promotes Tfeb induction
Having established a role for PEG3 in regulating TFEB
expression via loss-of-function experiments, we next ascertained the ability of PEG3 alone to drive TFEB. To this end, we
transiently transfected PAER2 cells with HA-tagged human
full-length PEG3 and evaluated porcine Tfeb. Following validation of increasing amounts of Peg3 via qPCR (data not shown),
we found a dose-dependent increase in Tfeb mRNA that
reached maximal output in as little as 300 ng (Fig. 2A) and
maintained saturation for up to 1.2 g of transfected PEG3
(Fig. 2A).
Next, immunoblot analyses showed that increasing amounts
of Peg3 promoted a significant increase in Tfeb starting with as
little as 100 ng of Peg3 (Fig. 2, B and C). Notably, the profile
obtained for Tfeb protein (Fig. 2B) paralleled that obtained for
the mRNA (Fig. 2A). Collectively, these data reinforce the concept that Peg3 is necessary and sufficient for driving Tfeb
expression and further substantiate the role of Peg3 in
autophagic progression.
We further corroborated the mRNA and protein data gained
via RNAi by generating PAER2 cells stably expressing human
PEG3 (denoted as PAER2PEG3) and empty vector– expressing
cells (PAER2pcDNA). This expression construct lacks the 3⬘
UTR (which harbors the siRNA recognition sites), rendering
PEG3 siRNA-resistant. As we found that PEG3 is required to
maintain basal TFEB (Fig. 1G), and de novo PEG3 is sufficient to
drive Tfeb mRNA and protein (cf. Fig. 2, A–C), we supertransfected the stable PEG3-expressing cells and evaluated whether
siRNA-resistant PEG3 could rescue Tfeb expression. Given the
close sequence homology between humans and pigs, endogenous Sus scrofa Peg3 was significantly reduced (Fig. 2D), but
exogenous expression of Homo sapiens PEG3 remained unperturbed (Fig. 2E). Evaluation of Tfeb demonstrated that stable
expression, analogous to transient expression, of PEG3 alone
drove Tfeb (Fig. 2F). Importantly, despite transfection of a
PEG3-specific siRNA, the presence of the siRNA-resistant
PEG3 maintained significantly induced Tfeb mRNA (Fig. 2F).
Structurally, PEG3 is composed of an N-terminal SCAN
domain required for protein–protein interactions and an
extended C terminus of 12 C2H2 Krüppel-like zinc fingers
(interspersed with proline-rich regions) for DNA binding and
transcriptional regulation (Fig. 2G) (23, 58, 59). Generating
HA-tagged truncation fragments (Fig. 2G) of either the
SCAN domain (HA-SCAN) or the zinc fingers (HA-ZF)
prevented nuclear translocation of these fragments following decorin stimulation in comparison with full-length HAtagged PEG3 (60). We therefore expressed these fragments
in our PAER2PEG3 cells and assayed Tfeb expression to determine whether they acted in a dominant negative fashion.
Surprisingly, HA-SCAN completely blocked PEG3-driven
Tfeb expression compared with empty vector–transfected
PAER2PEG3 cells (Fig. 2H). Introduction of HA-ZF resulted
in significantly abrogated Tfeb levels (Fig. 2H). Interestingly,
transfection of HA-ZF alone in PAER2pcDNA was sufficient
to drive Tfeb mRNA, suggesting a posttranscriptional path-
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Figure 1. Decorin evokes TFEB in a PEG3-dependent manner. A and B, immunoblot and quantification of PEG3 and TFEB in HUVECs treated with
decorin over time. C and D, identical experiment as in A and B in PAER2 cells. E, PEG3 knockdown in the presence of decorin in combination with scramble
siRNA (siScr) or siPEG3. F, TFEB analysis as in E. G, PEG3 and TFEB following PEG3 knockdown and challenge with decorin. H, identical RNAi verification
experiment as in E but for TFEB. I, similar experiment as in F but for PEG3. J, similar experiment as in G but in the presence of siScr or siTFEB following
decorin. GAPDH served as an internal loading control in A, C, G, and J. Gene expression in E, F, H, and I was normalized to ACTB. For the immunoblots in
A, C, G, and J and quantifications in B and D, data are representative of three independent biological replicates each for PAER2 cells or HUVECs. The data
in E, F, H, and I represent three independent biological replicates each for PAER2 cells or HUVECs. Statistical analyses were done via one-way ANOVA. **,
p ⬍ 0.01; ***p ⬍ 0.001.

way, as HA-ZF does not enter the nucleus (60). Collectively,
these data establish that PEG3 is required for decorin-mediated TFEB induction and place PEG3 upstream of TFEB.
TFEB induction relies on VEGFR2 and AMPK signaling
Endothelial cell autophagy in response to soluble decorin
proceeds in a VEGFR2/AMPK-dependent manner (31, 34). To
address the role of AMPK, we utilized Compound C (dorsomorphin), a potent and reversible ATP-competitive inhibitor of

AMPK that directly interacts with the catalytic ␣ subunit (37).
Compound C significantly abolished decorin-evoked TFEB
induction (Fig. 3A). Moreover, blocking the kinase activity of
VEGFR2 with SU5416 also prevented an increase in TFEB (Fig.
3A). In both cases, TFEB was excluded from the nuclear compartment when the kinase activity of either AMPK or VEGFR2
was abrogated (Fig. 3A).
We then tested whether the transcriptional induction of
TFEB was dependent on AMPK and VEGFR2. Blocking either
J. Biol. Chem. (2017) 292(39) 16211–16220
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Figure 2. Exogenous PEG3 drives TFEB. A, Tfeb following increasing amounts of transfected PEG3. B and C, immunoblots (B) and quantification (C) for PEG3
and endogenous Tfeb. D, E, and F, analyses of endogenous Sus scrofa Peg3 (D), H. sapiens PEG3 (E), or Sus scrofa Tfeb (F) following supertransfection of either siScr
or siPEG3 in control PAER2 cells (PAER2pcDNA) or stably expressing PEG3 PAER2 cells (PAER2PEG3) cells. G, schematic depicting known domains of full-length
PEG3 and resulting HA-tagged truncations. H, expression analysis of Tfeb following supertransfection of HA-SCAN or HA-ZF into PAER2pcDNA or PAER2Peg3
cells. The gene expression analyses in A, D, E, F, and H were normalized to ACTB. Gapdh served as an internal loading control in B. The quantifications in C are
representative of three independent biological replicates in PAER2 cells. The data in A, D, E, F, and H represent three independent biological replicates in PAER2
cells. Statistical analyses were done via one-way ANOVA. **, p ⬍ 0.01; ***, p ⬍ 0.001.

AMPK (Fig. 3B) or VEGFR2 (Fig. 3C) significantly prevented
decorin-evoked TFEB expression. These results were extended
at the protein level insofar as Compound C (Fig. 3D) or SU5416
(Fig. 3E) precluded an increase in TFEB following decorin stimulation. We conclude that decorin requires the VEGFR2–
AMPK signaling axis for proficient nuclear translocation of
TFEB protein and proper induction of TFEB.
Autophagosome formation and autophagic flux require TFEB
A hallmark of autophagy is the induction of Beclin 1
and conversion of LC3-I to its phosphatidylethanolamineconjugated form, LC3-II, coincident with the formation of
dually positive Beclin 1 and LC3 autophagosomes (35, 61, 62).
As decorin requires PEG3 for proper expression of Beclin 1 and
LC3, we evaluated the role of TFEB in mediating Beclin 1 and
LC3 induction following decorin treatment. Silencing TFEB
not only prevented basal levels of BECN1 (Fig. 3F) and
MAP1LC3A (Fig. 3G) but severely impaired expression of both
genes in response to decorin (Fig. 3, F and G).
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Investigating Beclin 1 and LC3 protein levels revealed a similar pattern insofar as loss of TFEB abrogated Beclin 1 induction
(Fig. 3H) but did not perturb the basal levels of Beclin 1 (Fig.
3H), in contrast to the loss of PEG3 (31). Further, in the presence of siScr, decorin promoted the conversion of LC3-I to
LC3-II, but loss of TFEB stopped formation of the lipidated
form (Fig. 2H). Interestingly, the basal levels of LC3-I appeared
to be lower in the absence of TFEB (Fig. 3H).
Further implicating TFEB for decorin-evoked autophagosome formation, we performed differential interference contrast (DIC) microscopy on HUVECs. Immunostaining for
Beclin 1 and LC3 in the presence of decorin led to the formation
of dually positive autophagosomes (Fig. 3I). Conversely, transient depletion of TFEB prevented autophagosome formation
following decorin application (Fig. 3I).
As TFEB has a role in the development of autophagosomes,
we evaluated whether TFEB is required for autophagic flux. We
transiently depleted TFEB and found substantially impaired
flux for LC3 and p62/SQSTM1 (two established autophagic
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Figure 3. Decorin evokes TFEB via VEGFR2/AMPK. A, confocal microscopy depicting TFEB (green) following decorin (6 h) alone or in combination with
Compound C (30 M) or SU5416 (30 M) in HUVECs. Nuclei (blue) were visualized with DAPI. Scale bar ⫽ 10 m. B and C, TFEB with decorin in combination with
Compound C (B) or with SU5416 (C). D and E, TFEB with decorin in combination (Compound C (D) or SU5416 (E)). F and G, BECN1 (F) or MAP1LC3A (G) following
TFEB knockdown (the same authenticated RNA samples as used in Fig. 1H). H, immunoblots depicting Beclin 1 and LC3 on the same samples as authenticated
in Fig. 1J. I, DIC microscopy of autophagosomes stained for Beclin 1 (green) and LC3 (red) following transfection of siScr or siTFEB in conjunction with decorin
(6 h). Nuclei (blue) were visualized with DAPI. Scale bar ⫽ 10 m. J, PAER2 cells transiently transfected with siScr or siTFEB and treated with Bafilomycin A1 (100
nM) and/or decorin (6 h). GAPDH served as an internal loading control in D, E, H, and J. The gene expression analyses in B, C, F, and G were normalized to ACTB.
For confocal microcopy in A and DIC in I, at least five and ten fields per condition, respectively, were captured for each of three biological replicates in HUVECs.
For the immunoblots in D, E, H, and J, data are representative of at least three independent biological replicates in HUVECs or PAER2 cells. The data B, C, F, and
G represent at least three independent biological replicates in HUVECs. Statistical analyses were done via one-way ANOVA. **, p ⬍ 0.01; ***, p ⬍ 0.001.

J. Biol. Chem. (2017) 292(39) 16211–16220
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Figure 4. Decorin promotes TFEB nuclear translocation in a PEG3-dependent manner. A, confocal microscopy of TFEB localization in HUVECs following
decorin. B, confocal microscopy of GFP-TFEB localization in PAER2 cells in the presence of Torin 1 (4 h, 20 M) or decorin (6 h). C, cytosolic and nuclear
fractionation of PAER2 cells transiently transfected with pcDNA or GFP-TFEB and stimulated with decorin (6 h). GFP-TFEB resolves around 100 kDa because of
fusion with GFP at the N terminus. D, biochemical fractionation in HUVECs following decorin. E, biochemical fractionation in HUVECs following transfection
with siScr or siPEG3 and stimulated with decorin. F, immunoprecipitation of transiently transfected PAER2 cells with HA-PEG3 and immunoblotted with anti-HA
or TFEB following treatment with decorin or rapamycin. G, confocal microscopy of HUVECs. Nuclei (false-colored red in A and B) were visualized with DAPI. Scale
bar ⫽ 10 m. In C, D, and E, GAPDH and Lamin A/C were used to define the cytoplasmic and nuclear fractions, respectively. For confocal microcopy in A, B, and
G, at least five fields/condition with z-stacks were captured for each of the three biological replicates in HUVECs or PAER2 cells. For the immunoblots in C, D, E,
and F, data are representative of at least three independent biological replicates.

substrates) following decorin (Fig. 3J). Intriguingly, application
of bafilomycin A1 alone appears to affect TFEB, suggesting that
TFEB is sensitive to perturbations in basal flux. These data reinforce the concept of a common pathway involving TFEB for the
induction of core autophagic genes, autophagosome formation,
and flux in response to decorin.
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Decorin promotes TFEB nuclear translocation in a
PEG3-dependent manner
It is well-established that suppression of mTORC1 signaling
results in TFEB translocation into the nucleus, where it induces
the transcription of genes required for lysosomal biogenesis
(49). Using confocal laser microscopy, we directly evaluated
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this process in response to decorin in HUVECs. Soluble decorin
promoted nuclear accumulation of endogenous TFEB over
time, with the appearance of yellow speckles at 6 h and broad
nuclear co-localization at 9 h (Fig. 4A). Moreover, the TFEB
signal increased concurrently, with a more punctate staining
pattern within the cytosol (Fig. 4A).
To further validate these findings and to directly visualize
movement of TFEB into the nucleus, we utilized an expression
vector harboring TFEB fused at the N terminus to GFP (GFPTFEB). As a positive control, we used Torin 1, a known
autophagic inducer that specifically inhibits mTORC1 and
mTORC2 (63). Both decorin and Torin 1 caused a marked
translocation of TFEB into the nuclei of PAER2 cells (Fig. 4B).
Next, we performed cytosolic and nuclear fractionation with
PAER2 cells transiently transfected with either pcDNA or GFPTFEB to recapitulate the confocal findings (Fig. 4C). We found
that decorin augmented GFP-TFEB within the nuclear
compartment over basal conditions. Moreover, decorin also
increased GFP-TFEB within the cytoplasmic compartment,
most likely as a result of mTOR suppression. We validated the
morphological analyses via fractionation of HUVECs (Fig. 4D).
Decorin promoted a progressive accumulation of TFEB in the
nuclear fraction and a corresponding increase of TFEB signal in
the cytosolic fraction (Fig. 4D). We included a longer exposure
of the membrane immunoreacted for TFEB to clearly demonstrate the presence of TFEB under vehicle conditions within the
cytoplasmic fraction.
Having shown a mechanistic dependence of TFEB induction
on PEG3 activity, we next evaluated the role of PEG3 on the
nuclear translocation of TFEB. Loss of PEG3 (Fig. 4E, cytosolic
fraction) prevented decorin-evoked TFEB accumulation in the
nuclei (Fig. 4E, nuclear fraction). Next, we determined whether
TFEB nuclear translocation was due to an interaction of PEG3
with TFEB following autophagic stimulation. We transiently
transfected PAER2 cells with HA-PEG3, immunoprecipitated
PEG3, and evaluated TFEB binding following stimulation with
decorin or rapamycin. We found that decorin and rapamycin
increased TFEB levels within the inputs but did not result in any
detectable interaction of PEG3 with TFEB (Fig. 4F). Thus, our
data indicate that PEG3 does not bind TFEB for translocation
and most likely utilizes an indirect pathway for nuclear translocation of TFEB (see below).
This result was morphologically verified, where decorin promoted an increase in PEG3 and TFEB (Fig. 4G) with accumulation of TFEB in the nucleus. However, following PEG3 silencing, basal TFEB protein levels decreased (Fig. 1G), precluding
TFEB translocation (Fig. 4G).
Collectively, these data support a role for decorin in promoting the nuclear localization of TFEB. This effect is dependent
upon Peg3 in maintaining basal TFEB levels for its consequent
nuclear translocation in endothelial cells.

Discussion
In this study, we report a novel, mechanistic link between a
master regulator of autophagy, PEG3 (31), and TFEB, a master
transcription factor required for lysosomal biogenesis and
autophagy (48). Decorin, signaling via VEGFR2 and AMPK,
transduces pro-autophagic cues for TFEB transcriptional

induction and subsequent nuclear translocation in a strictly
PEG3-dependent manner. These functions are biologically
compatible with findings that posit decorin as a soluble, matrixderived autophagic inducer necessary for endothelial cell
autophagy (31), tumor cell mitophagy (64), and proper in vivo
autophagic flux in cardiac muscle (65). Further, decorin expression appears to be transcriptionally up-regulated under conditions of organismal stress (e.g. sepsis (66) and starvation (65,
67)). Autophagic induction may underlie the core mechanisms
that permit decorin to suppress tumorigenesis and angiogenesis
(16). Intriguingly, these findings may also be applicable to TFE3, a
TFEB homologue also responsive to autophagic stimuli (68).
Several insights into the mechanism of decorin-evoked
endothelial cell autophagy can be deduced from these findings
that may also be applicable to other pro-autophagic matrix
molecules and proteoglycans (9). Unlike the requirement of
PEG3 to maintain basal levels of both Beclin 1 mRNA and protein (31), it appears that PEG3 is recruited for TFEB expression
only under induced conditions and not for maintaining basal
TFEB levels. However, PEG3 loss does affect basal levels of
TFEB protein, suggesting a post-translational role for conferring TFEB stability.
A similar role for TFEB has emerged in possibly orchestrating decorin-dependent conversion of LC3-I to lipidated LC3-II,
perhaps via one of the CLEAR network targets TFEB is known
to regulate (69). Alternately, TFEB has recently been linked to
regulating cellular lipid metabolism via an autoregulatory loop
(70), and, in conjunction with the known role of lipid regulation
by autophagy (71), it is possible that the conversion defect of
LC3 is rooted in abnormal lipid processing upon TFEB loss.
Moreover, we have shown, for the first time, a role for TFEB in
mediating the formation of Beclin 1/LC3-positive autophagosomes as well as maintaining autophagic flux downstream of
external stimuli for autophagic induction within endothelial cells.
As decorin requires AMPK for efficient TFEB induction and
nuclear localization, it is possible that a pathway involving AMPK/
SKP2/CARM1 (54) might be engaged downstream of the
decorin–VEGFR2–AMPK signaling axis. It would be of interest to
evaluate, in future studies, the recruitment of CARM1, a histone
arginine methyltransferase, to TFEB-positive transcriptional complexes at target promoters following decorin, as has been shown
for traditional autophagic stimuli (54).
Collectively, we have identified a crucial downstream transcription factor for decorin-evoked autophagy that provides a
more detailed understanding of the core processes operating
during autophagic induction. Moreover, we have linked, for the
first time, decorin to lysosomal homeostasis, a key facet of
autophagy. In-depth investigations into the signaling pathways
and elucidation of the primary components decorin utilizes will
ultimately provide innovative and effective autophagy-based
(73) therapeutic targets and solutions for human disease and
cancer progression.

Experimental procedures
Cells, chemicals, and reagents
HUVECs were obtained from Lifeline Cell Technology
(Frederick, MD), grown in basal medium supplemented with
J. Biol. Chem. (2017) 292(39) 16211–16220
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the VascuLife EnGS LifeFactors Kit (Lifeline Cell Technology),
and used within the first five passages. Porcine aortic endothelial cells overexpressing VEGFR2 were described previously
(74, 75). Rabbit polyclonal antibodies against TFEB, Lamin
A/C, and GAPDH were obtained from Cell Signaling Technology. Rabbit antibody against Peg3 and goat polyclonal LC3 antibody were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA). Rabbit polyclonal anti-LC3B, Compound C, and
SU5416 were purchased from Sigma. The rabbit-anti-Beclin 1
and HRP-conjugated goat anti-rabbit and donkey anti-mouse
secondary antibodies were obtained from EMD Millipore (Billerica, MA). A custom rabbit polyclonal antibody (denoted
P164) against the N-terminal human SCAN domain of Peg3
(spanning 14 amino acids from 164 –177) was used for imaging.
Torin 1 was purchased from Tocris (Bristol, UK). All primary
antibodies were used at 1:1000 dilution in 1% BSA/TBST (Trisbuffered saline with Tween 20), except for GAPDH, which was
used at 1:10,000. For immunofluorescence, primary antibodies
were used at 1:200 in 1% BSA in PBS. Secondary antibodies for
chemiluminescence were used at 1:5000 in the same buffer as
above. SuperSignal West Pico enhanced chemiluminescence
substrate was purchased from Thermo Fisher Scientific. Purification and validation of human recombinant decorin have
been described elsewhere (22). Highly purified decorin proteoglycan (for purity, see Buraschi et al. (31)) was used at 200 nM
throughout the study.
Transient DNA and RNAi-mediated silencing
We transiently transfected PAER2 cells with increasing
amounts of plasmid encoding HA-Peg3 using Lipofectamine
2000 (Life Technologies) in Opti-MEM (Gibco). Expression
was verified by qPCR or immunoblotting where appropriate
(see below). A full description of the DNA transfection protocol
has been provided elsewhere (64). HUVECs were transiently
transfected using Lipofectamine RNAiMAX (Life Technologies) mixed with siRNA against H. sapiens PEG3 or TFEB
mRNA (Santa Cruz Biotechnology). Scrambled siRNA (sc37007, Santa Cruz Biotechnology) served as a control for
all siRNA experiments presented here. The protocol for
siRNA-mediated silencing is described elsewhere (55).
Immunofluorescence and confocal laser microscopy
Typically, ⬃5 ⫻ 104 HUVECs were plated on 0.2% gelatincoated 4-well chamber slides (Nunc, Thermo Scientific) and
grown to full confluence in their growth media at 37 °C. Cells
were subjected to immunofluorescence studies as described
before (76, 77). Slides were incubated with conjugated secondary antibodies such as goat anti-rabbit IgG Alexa Fluor威 488
and goat anti-mouse IgG Alexa Fluor威 564 (Invitrogen). Nuclei
were visualized with DAPI (Vector Laboratories).
Immunofluorescence images were acquired with a ⫻63, 1.3
oil immersion objective on a Leica DM5500B microscope
equipped with the Leica application suite and advanced fluorescence v1.8 software (Leica Microsystems, Frankfurt, Germany). Confocal analyses were carried out utilizing a ⫻63, 1.3
oil immersion objective of a Zeiss LSM-780 confocal laserscanning microscope with Zen imaging software. Images were
captured as part of a z-stack series with 3-m optical slices. A

16218 J. Biol. Chem. (2017) 292(39) 16211–16220

full description of the immunofluorescence and confocal laser
microscopy protocol can be found elsewhere (31).
Quantitative real-time PCR
Expression analysis by quantitative real-time PCR (qPCR)
was carried out on subconfluent 6-well plates seeded with ⬃2 ⫻
105 HUVECs or PAER2 cells and harvested in TRIzol reagent
(Invitrogen) following the appropriate experimental conditions. Gene expression analysis was performed on a Roche
LightCycler 480-II and calculated with the comparative Ct
(thermal cycle) method. A full description can be found in Refs.
31, 72.
Cytosolic and nuclear fractionation
Approximately 2 ⫻ 105 HUVECs were seeded and treated
according to the experimental conditions. NE-PER nuclear
and cytoplasmic extraction reagents (Thermo Fisher) were
used for fractionation according to the instructions of the
manufacturer.
Quantification and statistical analysis
Immunoblots were quantified by scanning densitometry
using Scion Image software (National Institutes of Health).
Graphs were generated using Sigma Stat 3.10. Experiments
with three or more comparison groups were subjected to oneway ANOVA followed by a Bonferroni post hoc test. Differences among the conditions were considered significant at p ⬍
0.05.
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